Chair: Alicia Aylott
Purpose: The Membership and Community Committee is responsible for coordinating all areas of membership and community support within PSI. In addition to recruiting new members and managing membership renewal, we work closely with the other PSI Committees to ensure that PSI delivers value for money to its members. The Membership and Community Committee meets a minimum of four times a year.
Our Activities:
We are always on the lookout for people to help support the PSI Community, if you are interested in getting involved in any of our activities and can spare even just a little bit of time, please get in touch with Nigel Howitt.
| Alicia Aylott | GSK | Chair |
| Priya Gokani | Amgen | Community engagement lead |
| Emma Crawford | ICON | DE&I lead |
| Nigel Howitt | Fortrea | Recruitment manager |
| Kate Tsirtsonis | Amgen | Committee member |
| Tim Rolfe | GSK | Committee member |
| Sophie Edmonds | Amgen | Committee member |
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This is an interactive online training workshop providing an in-depth review of the estimand framework as laid out by ICH E9(R1) addendum with inputs from estimand experts, case studies, quizzes and opportunity for discussions. You will develop an estimand in a therapeutic area of interest to your company. In an online break-out room, you will join a series of team discussions to implement the estimand framework in a case study, aligning estimands, design, conduct, analysis, (assumptions + sensitivity analyses) to the clinical objective and therapeutic setting.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Who is this event intended for? Statisticians with an interest understanding dose-finding in oncology. What is the benefit of attending? Learn about the state of oncology dose finding, particularly in light of current FDA guidance.
The book club’s usual focus is to read and discuss professional development books. In this short format event you can more easily develop you career without the commitment of reading the whole book - simply listen to the 1-hour long podcast before joining the interactive session on 21 May.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
The Institute of Cancer Research are seeking to appoint a Research Group Leader to join The CRUK Clinical Trials and Statistics Unit at the ICR.
The BioMarin internship programme will enable students to gain valuable experience and knowledge of the processes and systems within BioMarin, whilst gaining an insight into the pharmaceutical/biotech industry.
